Purinergic receptors in the rat lens: Activation of P2X receptors following hyperosmotic stress

Investigative Ophthalmology and Visual Science

Volumn 51, Issue 8, 2010, Pages 4156-4163

  Suzuki Kerr, Haruna ^a   Lim, Julie C ^a   Donaldson, Paul J ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

PURINERGIC P2X RECEPTOR; PURINERGIC P2X1 RECEPTOR; PURINERGIC P2Y RECEPTOR; PURINERGIC P2Y1 RECEPTOR; PURINERGIC RECEPTOR; ADENOSINE DIPHOSPHATE; DRUG DERIVATIVE; HYPERTONIC SOLUTION; ISOTONIC SOLUTION; N(6) METHYL 2' DEOXYADENOSINE 3',5' DIPHOSPHATE; N(6)-METHYL-2'-DEOXYADENOSINE 3',5'-DIPHOSPHATE; PURINERGIC P2 RECEPTOR; PURINERGIC P2Y12 RECEPTOR; PYRIDOXAL 5 PHOSPHATE; PYRIDOXAL PHOSPHATE 6 AZOPHENYL 2',4' DISULFONIC ACID; PYRIDOXAL PHOSPHATE-6-AZOPHENYL-2',4'-DISULFONIC ACID;

ANIMAL TISSUE; ARTICLE; CELL MEMBRANE; CELL STRUCTURE; CELL SWELLING; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CROSS REACTION; EXTRACELLULAR SPACE; FEMALE; HYPEROSMOTIC STRESS; IMMUNOHISTOCHEMISTRY; LENS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; ANIMAL; CYTOPLASM; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; FLUORESCENT ANTIBODY TECHNIQUE; ION TRANSPORT; METABOLISM; ORGAN CULTURE TECHNIQUE; OSMOSIS; WISTAR RAT;

ADENOSINE DIPHOSPHATE; ANIMALS; CELL MEMBRANE; CYTOPLASM; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HYPERTONIC SOLUTIONS; ION TRANSPORT; ISOTONIC SOLUTIONS; LENS, CRYSTALLINE; MALE; MICROSCOPY, CONFOCAL; ORGAN CULTURE TECHNIQUES; OSMOSIS; PYRIDOXAL PHOSPHATE; RATS; RATS, WISTAR; RECEPTORS, PURINERGIC P2;

EID: 77955869457     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.09-5023     Document Type: Article

References (53)

1. Crooke A, Guzmán-Aranguez A, Peral A, Abdurrahman MKA, Pintor J. Nucleotides in ocular secretions: their role in ocular physiology. Pharmacol Ther. 2008;119:55-73.
2. Burnstock G, Knight GE. Cellular distribution and functions of P2 receptor subtypes in different systems. Int Rev Cytol. 2004;240: 31-304.
3. Burnstock G. Purine and pyrimidine receptors. Cell Mol Life Sci. 2007;64:1471-1483.
4. North RA. Molecular physiology of P2X receptors. Physiol Rev. 2002;82:1013-1067.
5. 2+ in lens cells. Invest Ophthalmol Vis Sci. 1997;38:855-865.
6. 2+ regulation of gap junctional coupling in lens epithelial cells. Am J Physiol Cell Physiol. 2001;281:C972-C981.
7. Churchill GC, Louis CF. Ca(2+) regulation in differentiating lens cells in culture. Exp Eye Res. 2002;75:77-85.
8. Riach RA, Duncan G, Williams MR, Webb SF. Histamine and ATP mobilize calcium by activation of H1 and P2U receptors in human lens epithelial cells. J Physiol. 1995;489:273-282.
9. Duncan G, Riach RA, Williams MR, Webb SF, Dawson AP, Reddan JR. Calcium mobilisation modulates growth of lens cells. Cell Calcium. 1996;19:83-89.
10. Collison DJ, Duncan G. Regional differences in functional receptor distribution and calcium mobilization in the intact human lens. Invest Ophthalmol Vis Sci. 2001;42:2355-2363.
11. Tamiya S, Okafor MC, Delamere NA. Purinergic agonists stimulate lens Na, K-ATPase-mediated transport via a Scr tyrosine kinasedependent pathway. Am J Physiol Cell Physiol. 2007;293:C790-C796.
12. Lurtz MM, Louis CF. Purinergic receptor-mediated regulation of lens connexin43. Invest Ophthalmol Vis Sci. 2007;48:4177-4186.
13. Eldred JA, Sanderson J, Wormstone M, Reddan JR, Duncan G. Stress-induced ATP release from and growth modulation of human lens and retinal pigment epithelial cells. Biochem Soc Trans. 2003; 31:1213-1215.
14. Rhodes JD, Collison DJ, Duncan G. Calcium activates SK channels in the intact human lens. Invest Ophthalmol Vis Sci. 2003;44: 3927-3932.
15. Hu RG, Suzuki-Kerr H, Webb KF, et al. Molecular and functional mapping of regional differences in P2Y receptor expression in the rat lens. Exp Eye Res. 2008;87:137-146.
16. Suzuki-Kerr H, Vlajkovic S, Donaldson PJ, Lim JC. Molecular identification and localization of P2X receptors in the rat lens. Exp Eye Res. 2008;86:844-855.
17. Suzuki-Kerr H, Lim J, Vlajkovic S, Donaldson P. Differential membrane redistribution of P2X receptor isoforms in response to osmotic and hyperglycemic stress in the rat lens. Histochem Cell Biol. 2009;131:667-680.
18. Bond J, Green C, Donaldson PJ, Kistler J. Liquefaction of cortical tissue in diabetic and galactosemic rat lenses defined by confocal laser scanning microscopy. Invest Ophthalmol Vis Sci. 1996;37: 1557-1565.
19. Young MA, Tunstall MJ, Kistler J, Donaldson PJ. Blocking chloride channels in the rat lens: localized changes in tissue hydration support the existence of a circulating chloride flux. Invest Ophthalmol Vis Sci. 2000;41:3049-3055.
20. Chee K, Kistler J, Donaldson PJ. Role for KCC transporters in the maintenance of lens transparency. Invest Ophthalmol Vis Sci. 2006;47:673-682.
21. Donaldson PJ, Chee K-SN, Lim JC, Webb KF. Regulation of lens volume: implications for lens transparency. Exp Eye Res. 2009;88: 144-150.
22. Jacobs MD, Donaldson PJ, Cannell MB, Soeller C. Resolving morphology and antibody labeling over large distances in tissue sections. Microsc Res Techn. 2003;62:83-91.
23. von Kugelgen I. Pharmacological profiles of cloned mammalian P2Y-receptor subtypes. Pharmacol Ther. 2006;110:415-432.
24. Lambrecht G, Braun K, Damer M, et al. Structure-activity relationships of suramin and pyridoxal-5'-phosphate derivatives as P2 receptor antagonists. Curr Pharmaceut Design. 2002;8:2371-2399.
25. Jacobson KA, Hoffmann C, Kim Y-C, et al. Molecular recognition in P2 receptors: ligand development aided by molecular modeling and mutagenesis. Prog Brain Res. 1999;120:119-132.
26. Kim Y-C, Camaioni E, Ziganshin AU, et al. Synthesis and structureactivity relationships of pyridoxal-6-arylazo-5-prime-phosphate and phosphonate derivatives as P2 receptor antagonists. Drug Dev Res. 1998;45:52-66.
27. Waldo GL, Harden TK. Agonist binding and Gq-stimulating activities of the purified human P2Y1 receptor. Mol Pharmacol. 2004; 65:426-436.
28. Lazarowski ER, Watt WC, Stutts MJ, Boucher RC, Harden TK. Pharmacological selectivity of the cloned human P2U purinoceptor: potent activation by diadenosine tetraphosphate. Br J Pharmacol. 1995;116:1619-1627.
29. Wildman SSP, King BF. P2X receptors: epithelial ion channels and regulators of salt and water transport. Nephron Physiol. 2008;108: 60-67.
30. Gever JR, Cockayne DA, Dillon MP, Burnstock G, Ford APDW. Pharmacology of P2X channels. Pflugers Archiv. 2006;452:513-537.
31. Leon C, Hechler B, Vial C, Leray C, Cazenave J-P, Gachet C. The P2Y1 receptor is an ADP receptor antagonized by ATP and expressed in platelets and megakaryoblastic cells. FEBS Lett. 1997; 403:26-30.
32. Chen ZP, Krull N, Xu S, Levy A, Lightman SL. Molecular cloning and functional characterization of a rat pituitary G protein-coupled adenosine triphosphate (ATP) receptor. Endocrinology. 1996;137: 1833-1840.
33. Chang K, Hanaoka K, Kumada M, Takuwa Y. Molecular cloning and functional analysis of a novel P2 nucleotide receptor. J Biol Chem. 1995;270:26152-26158.
34. Bogdanov YD, Wildman SS, Clements MP, King BF, Burnstock G. Molecular cloning and characterization of rat P2Y4 nucleotide receptor. Br J Pharmacol. 1998;124:428-430.
35. 2+ ions. Br J Pharmacol. 2003;140:1177-1186.
36. Erhardt JA, Toomey JR, Douglas SA, Johns DG. P2X1 stimulation promotes thrombin receptor-mediated platelet aggregation. J Thromb Haemost. 2006;4:882-890.
37. Furuya K, Sokabe M, Furuya S. Characteristics of subepithelial fibroblasts as a mechano-sensor in the intestine: cell-shape-dependent ATP release and P2Y1 signaling. J Cell Sci. 2005;118:3289-3304.
38. Baurand A, Raboisson P, Freund M, et al. Inhibition of platelet function by administration of MRS2179, a P2Y1 receptor antagonist. Eur J Pharmacol. 2001;412:213-221.
39. Kim YC, Brown SG, Harden TK, et al. Structure-activity relationships of pyridoxal phosphate derivatives as potent and selective antagonists of P2X1 receptors. J Med Chem. 2001;44:340-349.
40. Collo G, North RA, Kawashima E, et al. Cloning of P2X5 and P2X6 receptors and the distribution and properties of an extended family of ATP-gated ion channels. J Neurosci. 1996;16:2495-2507.
41. Surprenant A, Rassendren F, Kawashima E, North RA, Buell G. The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7). Science. 1996;272:735-738.
42. Boyer JL, Mohanram A, Camaioni E, Jacobson KA, Harden TK. Competitive and selective antagonism of P2Y1 receptors by N6-methyl 2'-deoxyadenosine 3',5'-bisphosphate. Br J Pharmacol. 1998;124:1-3.
43. Perng MD, Quinlan RA. Seeing is believing! The optical properties of the eye lens are dependent upon a functional intermediate filament cytoskeleton. Exp Cell Res. 2005;305:1-9.
44. Villa PG, Henzel WJ, Sensenbrenner M, Henderson CE, Pettmann B. Calpain inhibitors, but not caspase inhibitors, prevent actin proteolysis and DNA fragmentation during apoptosis. J Cell Sci. 1998;111:713-722.
45. Carragher NO, Frame MC. Focal adhesion and actin dynamics: a place where kinases and proteases meet to promote invasion. Trends Cell Biol. 2004;14:241-249.
46. Dutton JL, Poronnik P, Li GH, et al. P2X(1) receptor membrane redistribution and down-regulation visualized by using receptorcoupled green fluorescent protein chimeras. Neuropharmacology. 2000;39:2054-2066.
47. Murrell-Lagnado RD, Qureshi OS. Assembly and trafficking of P2X purinergic receptors (review). Mol Membr Biol. 2008;25:321-331.
48. Zampighi GA, Eskandari S, Kreman M. Epithelial organization of the mammalian lens. Exp Eye Res. 2000;71:415-435.
49. Lovicu FJ, McAvoy JW. Growth factor regulation of lens development. Dev Biol. 2005;280:1-14.
50. Mitchell CH. Release of ATP by a human retinal pigment epithelial cell line: potential for autocrine stimulation through subretinal space. J Physiol. 2001;534:193-202.
51. Duncan G, Bushell AR. Ion analyses of human cataractous lenses. Exp Eye Res. 1975;20:223-230.
52. Duncan G, Hightower KR, Gandolfi SA, Tomlinson J, Maraini G. Human lens membrane cation permeability increases with age. Invest Ophthalmol Vis Sci. 1989;30:1855-1859.
53. Pasino M, Maraini G. Cation pump activity and membrane permeability in human senile cataractous lenses. Exp Eye Res. 1982;34: 887-893.